Redica Systems
  • Login
  • Request a Demo
  • Products
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
  • Solutions
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
  • Data & Services
    • Redica App
    • Catalyst
  • Company
    • About Us
    • People
    • Careers
    • Press
  • Resources
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
Redica Systems
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
    • Redica App
    • Catalyst
    • About Us
    • People
    • Careers
    • Press
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Login
  • Request a Demo

Resources

Webinar – FDA GCP Inspection Trends Identified Using AI

Redica Systems Announces Addition of Larry Coble as Chief Revenue Officer

PLEASANTON, CA, June 1, 2022 — Redica Systems has announced a critical addition to its executive leadership team with the hiring of Larry Coble as the Chief Revenue Officer. Larry is an industry veteran and transformative leader well-versed in building performance-driven teams and scaling successful software companies. He will lead the commercial vision and strategy […]

Report – 4 GMP Case Studies Including FDA Findings and Concerns

Webinar – Are Laboratories Perpetuating Data Integrity Problems?

Redica Systems Appoints New CTO to Accelerate Technological Innovation in the Next Stage of Growth

PLEASANTON, CA, May 3, 2022 —  Redica Systems, a global leader in data and software for regulatory and quality intelligence to FDA-regulated industries, has been actively expanding its leadership team—and today announced that Arijit Saha has joined the executive team as Chief Technology Officer. Saha brings to the team deep technical experience—with a background in […]

Report – Analysis of 2021 U.S FDA 483 GMP Observations

Webinar – Bringing Innovation to Regulatory Intelligence from Ideation to Success

Report – Yes, Warehouses that Store and Distribute FDA Regulated Products Must Comply with Relevant GMPs

Report – UDI-related Issues in Form 483s: Where Should You Focus Mitigation Efforts?

Report – Analysis of FDA Drug GMP Warning Letters for FYs 2020 and 2021

« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2025 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status